AKT1 and lip and oral cavity carcinoma: In our study, we observed that intervention with solanine affected the EGFR-mediated PI3K/Akt/NF-κB signaling pathway, effectively reducing inflammation, cell proliferation, and angiogenesis in aggressive drug-resistant oral carcinoma cells.